Intelligent Pain Management System using Synergistic Combinations

Publication ID: 24-11857520_0008_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Intelligent Pain Management System using Synergistic Combinations,” Published Technical Disclosure No. 24-11857520_0008_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857520_0008_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,520.

Summary of the Inventive Concept

A novel system integrating a preservative-free intranasal composition of lidocaine with advanced technologies such as AI, IoT, blockchain, and new materials to provide personalized, optimized, and trackable pain management solutions.

Background and Problem Solved

The original patent disclosed a preservative-free intranasal composition of lidocaine for treating various pain conditions. However, it lacked the capabilities to monitor patient dosage, optimize treatment regimens, and provide personalized care. The new inventive concept addresses these limitations by combining the original composition with cutting-edge technologies to create a more effective and efficient pain management system.

Detailed Description of the Inventive Concept

The system comprises a preservative-free intranasal composition of lidocaine, a mechanical pump metered dose spray device, and a blockchain-based tracking system for monitoring patient dosage and treatment outcomes. Additionally, it incorporates an AI-powered diagnostic tool for identifying optimal dosage and treatment regimens, an IoT-enabled sensor for tracking patient vital signs, and a mobile application for remote monitoring and treatment adjustment. The system also utilizes a novel material composition for enhanced bioavailability and efficacy. Furthermore, it integrates a genetic testing platform for identifying genetic markers associated with pain sensitivity and an AI-powered treatment optimization algorithm for personalized pain management.

Novelty and Inventive Step

The new inventive concept introduces the synergistic combination of a preservative-free intranasal composition of lidocaine with advanced technologies, providing a novel and non-obvious solution for pain management. The integration of blockchain, AI, IoT, and new materials enables real-time monitoring, personalized treatment, and optimized outcomes, which is not disclosed in the original patent.

Alternative Embodiments and Variations

Alternative embodiments of the system may include using different AI algorithms, varying the type of IoT sensors, or incorporating additional technologies such as virtual or augmented reality. The system may also be adapted for use in different pain management applications, such as post-operative care or chronic pain management.

Potential Commercial Applications and Market

The Intelligent Pain Management System has significant commercial potential in the healthcare industry, particularly in the areas of pain management, telemedicine, and personalized medicine. The system's ability to provide optimized and trackable pain management solutions can improve patient outcomes, reduce healthcare costs, and increase market share for pharmaceutical companies and healthcare providers.

CPC Classifications

SectionClassGroup
A A61 A61K31/167
A A61 A61K9/0043
A A61 A61M11/00
A A61 A61M2210/0618

Original Patent Information

Patent NumberUS 11,857,520
TitleTherapeutic composition of intranasal lidocaine
Assignee(s)Nortic Holdings Inc.